EN
登录

AI成像和分析解决方案提供商Orbem获得5550万欧元B轮融资,由Innovation Industries领投

Orbem secures €55.5 million Series B

D-Pharm 等信源发布 2026-01-22 10:28

可切换为仅中文


Orbem, the Munich-based Deep tech company turning

奥贝姆,这家总部位于慕尼黑的深科技公司正在转变

magnetic resonance imaging

磁共振成像

(MRI) into a powerful, AI-powered tool to reveal hidden insights in

(MRI)转化为一个强大的、由人工智能驱动的工具,以揭示隐藏的见解

food

食物

and

biology

生物学

, announced the successful closing of a €55.5 million

,宣布成功完成了5550万欧元的融资

Series B financing

B轮融资

round. The round is led by European Deep tech specialist Innovation Industries and joined by Supernova Invest, with significant follow-on participation from existing investors General Catalyst, 83North, The Venture Collective, Possible Ventures, and several angel investors.

这一轮融资由欧洲深度科技专家 Innovation Industries 领投,Supernova Invest 跟投,现有投资者 General Catalyst、83North、The Venture Collective、Possible Ventures 以及多位天使投资人也积极参与跟投。

Symbolic image

符号图像

AI-generated image

人工智能生成的图像

Orbem has developed a breakthrough platform that makes MRI technology fast, affordable and scalable, enabling non-invasive analysis of biological materials at an industrial scale. By doing so, the company is building what is becoming the industry's largest and most comprehensive biological dataset. Already profitable and a leading provider of in-ovo sexing in five European countries, a position built on its deep understanding of poultry industry processes, Orbem will use the new capital to fuel its expansion into the United States, launch new solutions for the poultry industry, and enter the multi-billion-dollar fruit and vegetable market.

Orbem开发了一个突破性的平台,使MRI技术变得快速、经济且可扩展,从而实现对生物材料在工业规模上的无创分析。通过这一方式,该公司正在构建成为行业内最大且最全面的生物数据集。Orbem已在五个欧洲国家实现盈利,并成为鸡蛋性别鉴定的领先提供商,这一地位建立在其对家禽行业流程的深刻理解之上。Orbem将利用新获得的资金推动其向美国市场扩张,推出面向家禽行业的新解决方案,并进入价值数十亿美元的水果和蔬菜市场。

Additionally, Orbem will invest in its vision to apply its actionable intelligence to human healthcare..

此外,Orbem 将投资于将其可操作智能应用于人类医疗保健的愿景。

Proven Success: Transparency in the Poultry Industry

事实证明的成功:家禽行业的透明度

Orbem has already delivered measurable impact in the poultry industry, leveraging its deep industry process knowledge to deliver practical solutions. Its flagship product, the Genus Focus, uses AI-powered MRI to see inside a poultry egg, non-invasively determining its sex in less than one second. This provides an animal-friendly and highly efficient alternative to the culling of male chicks, a practice now banned in several EU countries.

Orbem已经在家禽行业产生了可衡量的影响,利用其深厚的行业流程知识提供实用的解决方案。其旗舰产品Genus Focus使用人工智能驱动的核磁共振成像技术,可以在不到一秒钟的时间内非侵入性地查看家禽蛋的内部并确定其性别。这为扑杀雄性雏鸡的做法提供了一种动物友好的高效替代方案,而扑杀雄性雏鸡的做法已在多个欧盟国家被禁止。

With over 170 million eggs scanned to date, Orbem is scaling rapidly, ready to meet increasing global demand spurred by initiatives like the new ‘Hatch Check’ certification in the US..

迄今为止,Orbem已经扫描了超过1.7亿枚鸡蛋,正在迅速扩展规模,准备满足由美国新的“孵化检查”认证等举措推动的全球需求增长。

Artificial intelligence is drastically changing the healthcare sector

人工智能正在彻底改变医疗保健行业

Companies are engaging with AI and investing in it, but only 29 percent feel well prepared to use GenAI for competitive advantage

公司正在积极接触人工智能并对其进行投资,但只有29%的公司认为自己已经准备好利用生成式人工智能来获取竞争优势。

Read news

读新闻

Building on this success, Orbem recently launched the Genus Scale, a first-of-its-kind product that sees inside eggs to check their fertilization status before incubation. This allows hatcheries to stop wasting valuable incubator space on non-viable eggs, repurposing them for the food industry, creating new revenue streams, and fighting food waste..

基于这一成功,Orbem最近推出了Genus Scale,这是一款首创的产品,可以在孵化前查看鸡蛋内部以检查其受精状态。这使得孵化场能够停止在非受精蛋上浪费宝贵的孵化器空间,将它们重新用于食品行业,创造新的收入来源,并对抗食品浪费。

A New Era of Growth: Scaling and Expansion

增长的新时代:规模化与扩展

The Series B funding will accelerate Orbem's mission to solve global challenges by revealing what we can’t see on the outside of food and biology. Key initiatives include:

B轮融资将加速Orbem通过揭示食品和生物学外部无法看到的内容,来解决全球挑战的使命。关键举措包括:

US Market Entry: After establishing its first US office in Houston, Texas, in 2025, Orbem is bringing its proven poultry solutions to one of the world's largest agricultural markets.

美国市场进入:Orbem于2025年在德克萨斯州休斯顿设立其首个美国办事处后,正将其经过验证的家禽解决方案引入全球最大的农业市场之一。

Expanded Poultry Platform: Orbem will continue to strengthen its commitment to the poultry industry, scaling its existing solutions.

扩展的家禽平台:Orbem 将继续加强其对家禽行业的承诺,扩大其现有解决方案。

New Vertical: Fruits & Vegetables: The company is expanding its actionable intelligence for sustainable food production into the fruit and vegetable sector. Orbem’s non-destructive technology can see inside produce like watermelons, avocados and mangoes to spot internal defects and assess quality without cutting them open.

新领域:水果和蔬菜:公司正在将可持续食品生产的可操作智能扩展到水果和蔬菜领域。Orbem的非破坏性技术可以透视西瓜、牛油果和芒果等农产品的内部,发现内部缺陷并评估质量,而无需切开它们。

This helps producers to sort goods with precision, ensure consistent quality, and dramatically reduce food waste before products reach the consumer..

这有助于生产商精确分类商品,确保质量一致,并在产品到达消费者之前大幅减少食品浪费。

Healthcare: What Orbem learns from scanning millions of eggs and avocados translates to a deeper understanding of biology. The company is building the world's largest biological dataset. This unique asset is the foundation for AI models that will have profound applications in human health, making non-invasive insights more accessible..

医疗保健:Orbem通过扫描数百万个鸡蛋和牛油果所学到的知识,转化为对生物学更深入的理解。该公司正在构建世界上最大的生物数据集。这一独特资产是人工智能模型的基础,该模型将在人类健康领域产生深远的应用,使非侵入性洞察更加普及。

Dr. Pedro Gómez, co-founder and CEO of Orbem, says: “We’re the first and so far only company in the world to demonstrate the use of MRI in less than one second and without humans in the loop. We began by showing the poultry industry what’s possible when you can see inside an egg, and we are just getting started.

奥贝姆公司联合创始人兼首席执行官佩德罗·戈麦斯博士说:“我们是世界上第一个,也是迄今为止唯一一家证明了核磁共振成像技术能在不到一秒钟内完成并且无需人工介入的公司。我们首先向家禽业展示了当你能够看到蛋内部时的可能性,我们才刚刚开始。"

This new funding allows us to accelerate our US expansion and help more food producers and healthcare providers make better decisions with data. Our scalable platform and our rapidly growing, proprietary biological dataset are the perfect basis for achieving this. We are proud to see the trust our investors have placed in us and our vision to help the world see from the inside out.”.

这笔新的资金使我们能够加快在美国的扩张,并帮助更多的食品生产商和医疗保健提供商利用数据做出更好的决策。我们可扩展的平台和快速增长的专有生物数据集为此提供了完美的基础。我们很自豪地看到投资者对我们的信任,以及对我们帮助世界由内而外看清事物的愿景的支持。

Pleuni Hooijman, Investment Manager at Innovation Industries, states: “Orbem is truly exceptional. Few companies manage to make such complex technology accessible and scalable across so many industries. With its platform, Orbem is already transforming entire sectors, and we are very pleased to join them on this journey.“.

创新产业公司的投资经理普勒尼·胡伊曼表示:“奥贝姆公司确实与众不同。很少有公司能够使如此复杂的技术在众多行业中变得可及且可扩展。通过其平台,奥贝姆已经在转变整个行业,我们非常高兴能在这段旅程中与他们携手同行。”

Michaël Thomas, Investment Director at Supernova Invest, adds:

Supernova Invest的投资总监迈克尔·托马斯补充道:

'We’re thrilled to join forces with Orbem, a visionary company that perfectly embodies Europe’s Deep tech excellence. By combining cutting-edge AI and MRI technologies, Orbem delivers concrete answers to some of the major challenges of our time, from reducing animal suffering to fighting food waste and building a more sustainable global food system.

“我们很高兴与 Orbem 携手合作,这是一家完美体现欧洲深度科技卓越性的前瞻性公司。通过结合尖端的人工智能和核磁共振技术,Orbem 为当今一些重大挑战提供了具体的解决方案,从减少动物痛苦到对抗食物浪费,再到构建更加可持续的全球食品体系。”

This investment illustrates our conviction that Europe can lead in physical AI, transforming scientific breakthroughs into meaningful industrial innovation.'.

这项投资体现了我们对欧洲能够在实体人工智能领域领先的信心,将科学突破转化为有意义的工业创新。

https://www.bionity.com/en/news/1187929/orbem-secures-55-5-million-series-b.html

https://www.bionity.com/en/news/1187929/orbem-secures-55-5-million-series-b.html

Cyber Valley unites AI & robotics expertise for the healthcare sector

Cyber Valley 联合了人工智能和机器人技术专长,应用于医疗保健领域。

New Cyber Valley Health Cluster connects research, start-ups, and companies in the field of AI and medicine

新网络谷健康集群连接了人工智能和医学领域的研究、初创企业和公司。

Read news

读新闻

Most read news

最热门的新闻

1

1

Could cheese protect your brain health?

奶酪能否保护你的大脑健康?

2

2

Common medicines may influence CRISPR therapy outcomes and precision cancer treatment

常见药物可能影响CRISPR治疗结果和精准癌症治疗

3

3

T-CURX raises $20M Series A for non-viral CAR-T therapies

T-CURX为其非病毒CAR-T疗法筹集2000万美元A轮融资

4

4

Stopping immune aging: Startup receives million-dollar investment

停止免疫衰老:初创公司获百万美元投资

5

5

How sweet is healthy? Tagatose could solve the sugar problem

健康有多甜?塔格糖可能解决糖的问题

Topics

主题

investments

投资

food technology

食品技术

artificial intelligence

人工智能

food

食物

biology

生物学

Series B financing

B轮融资

healthcare

医疗保健

eggs

鸡蛋

quality

质量

avocados

牛油果

magnetic resonance imaging

磁共振成像

health

健康

food industry

食品工业

food production

食品生产

Show all

显示全部

Show less

显示更少

Organizations

组织机构

ORBEM

奥贝姆